The domestic markets inched higher during the initial hours of Tuesday, thanks to positive investor sentiment and good corporate results. Meanwhile, Medicamen Biotech reported stellar Q4 numbers as standalone revenue grew 62% YoY to Rs 37.49 crore as compared to Rs 23.09 crore in March 2022. Also, net profits jumped 47% YoY to Rs 4.04 …